Why these 2 small-cap shares have doubled in value in a year

The ASX Small Ordinaries index has performed strongly over the past 12 months. Here are two small-cap shares that have doubled in value in that time.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX Small Ordinaries index has performed strongly over the past 12 months – up almost 16% compared to 9% for the S&P/ASX 200.

There have been a few standout performers in the small-cap index – notably the two companies below.

Clover Corporation Limited (ASX: CLV)

Clover Corporation has a market cap of about $259 million. It is engaged in the business of the refining and sale of omega-3 oils used in infant formula, supplements, and medical foods. As a mostly B2B business rather than a consumer brand-centric business, I think it represents a less risky play for investors than the pure infant formula businesses such as Bellamy's Australia Limited (ASX: BAL) and Bubs Australia Ltd (ASX: BUB).

Clover had a cracking results season which didn't seem to attract much attention. Revenue increased by 32% to $62.9 million and net profit increased by 109% to $7.6 million. The company also finished the financial year with a strong balance sheet and holding about $7.9 million in cash.

What I really like about Clover is the growth opportunities. The EU has passed legislation that all infant formula sold within its borders by 2020 must contain a prescribed minimum level of Omega 3. This provides Clover with a massive opportunity together with their investments in new products and manufacturing facilities.

Clover Corporation shares are trading at $1.58 on a PE of about 34 compared to Bellamy's of 27 – so it is not cheap. However, it's Price Earnings to Growth (PEG) ratio is about 1 so I don't think the company is overvalued given its potential.

Nearmap Ltd (ASX: NEA)

Nearmap has a market cap of about $770 million. It provides geospatial maps and aerial imaging technology for governments and private enterprise clients in Australia, New Zealand, and the United States.

Nearmap's earnings for 2018 were impressive – 2-year 35% annual compound growth in ACV (annual contract value) to $66.2 million in 2018. The share of revenue from US operations grew from 20% in 2017 to 26% in 2018 to $17.4 million. What's exciting investors with Nearmap is the addressable market, which in the US alone is estimated to be worth over $1 billion.

Although the company reported an $8 million loss for 2018, this was largely due to increased expenditure on sales and marketing in the United States. The Australian operations reported a segment profit of about $22 million on sales of $42 million. This highlights the potential earnings powerhouse this business could be if it captures a material share of the US addressable market.

Nearmap shares are trading at $1.74. This is about 12 times current revenue. Investors are clearly looking at the growth potential of this business. However, achieving market dominance in America will not be easy. There are some dominant players like Eagleview and ESRI which will present competitive challenges for Nearmap. How well it executes on the US strategy will determine the share price trajectory over the next 12 months.

Motley Fool contributor matthew reynolds owns shares of Clover Limited and Nearmap Ltd. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

These ASX growth shares are being tipped to smash the market

Returns of 14% to 68% could be on the cards for buyers of these shares according to brokers.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Growth Shares

These ASX 200 growth shares could rise 50% to 70%

Analysts are predicting these stocks to rise materially from current levels.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

2 ASX 300 growth shares with 'strong momentum' this fund manager says are buys

These two stocks have plenty of growth potential, according to experts.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 high-growth ASX shares to buy now

Analysts at Bell Potter think these shares would be great picks for growth investors.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth stocks could rise 30% to 100%

Analysts think these shares are dirt cheap at current levels and have put buy ratings on them.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Goldman Sachs loves these ASX 200 growth shares: Do you own them?

Why is the broker bullish on them? Let's find out.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 super ASX growth shares to buy for huge returns

Analysts are feeling bullish about these shares. Let's see what they are saying about them.

Read more »

A fresh-faced young woman holds an Australian flag aloft above her head as she smiles widely on a beach as though celebrating a national day or event where Australia has been successful.
Growth Shares

The best Australian shares to buy with $1,000 right now 

Analysts think these shares could be great options for Aussie investors when the market reopens.

Read more »